Skip to Content

Join the 'Postoperative Ocular Inflammation' group to help and get support from people like you.

Postoperative Ocular Inflammation News

Icon Bioscience Receives FDA Approval for Dexycu (dexamethasone intraocular suspension) for Treating Inflammation Associated With Cataract Surgery

Posted 8 days ago by Drugs.com

Newark, CA (February 12, 2018) – Icon Bioscience, Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular eye-care therapeutics, today announced that the United States Food and Drug Administration (FDA) has approved IBI’s New Drug Application (NDA) for Dexycu (dexamethasone intraocular suspension), a dropless, long ...

Sun Pharma Receives FDA Approval For BromSite (bromfenac ophthalmic solution)

Posted 12 Apr 2016 by Drugs.com

Mumbai, April 09, 2016: Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today announced that one of its wholly owned subsidiaries has received approval from USFDA for its New Drug Application (NDA) related to BromSite™ (bromfenac ophthalmic solution) 0.075% for the treatment of p ...

Bausch + Lomb Receives FDA Approval for Prolensa

Posted 8 Apr 2013 by Drugs.com

MADISON, NJ - Bausch + Lomb, the global eye health company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for Prolensa (bromfenac ophthalmic solution) 0.07 percent prescription eye drop, an innovative once-daily nonsteroidal anti-inflammatory drug (NSAID) for the treatment of postoperative inflammation and reduction of ...

ISTA Pharmaceuticals Receives FDA Approval for Bromday

Posted 20 Oct 2010 by Drugs.com

IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ – ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for Bromday (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have ...

Ask a Question

Further Information

Related Condition Support Groups

Ophthalmic Surgery

Related Drug Support Groups

Pred Forte, Durezol, Lotemax, Nevanac, Omnipred, Ilevro, loteprednol, Acular, Alrex, view more... Prednisol, dexamethasone / tobramycin, Econopred Plus, Xibrom, Prolensa, Econopred, BromSite, Acular LS, Pred Mild, Bromday, Vexol, Acuvail, Inflamase Forte, difluprednate, Omidria, nepafenac, rimexolone, Inflamase Mild, Ocu-Pred-A, Ocu-Pred Forte, Ocu-Pred, ketorolac / phenylephrine, Voltaren Ophthalmic, Ocufen, Acular PF, AK-Pred, Dexycu